Pyrytyon zinc | Skin-cap aerosol external 0.2% 35 g

Release form

Aerosol for external use.

packaging

aerosol can 35 g.

Pharmacological action of

Pharmacotherapeutic group:

Dermatoprotective agent

ATX code [D11AX12]

Pharmacological properties:

Pharmacodynamics:

Activated zinc has anti-inflammatory and anti-inflammatory effects. Antifungal activity is especially pronounced when acting on Pityrosporum ovale and Pityrosporum orbiculare, causing inflammation and excessive peeling with dandruff, seborrhea, psoriasis and other skin diseases. The antibacterial activity of zinc pyrithione is manifested in relation to a number of pathogenic microorganisms (streptococcus, staphylococcus, Pseudomonas aeruginosa, Escherichia coli, Proteus, etc.) Zinc pyrithione reduces intracellular ATP level, contributes to the depolarization of cell membranes, causing the death of fungi and bacteria.

Pharmacokinetics:

When applied topically, activated pyrithione zinc is deposited in the epidermis and surface layers of the dermis. Systemic absorption occurs slowly. It is found in blood in trace amounts.

Indications

Psoriasis, atopic dermatitis (eczema, neurodermatitis), seborrheic dermatitis in adults and children from 1 year old.

Contraindications

Hypersensitivity to the components of the drug.

Use during pregnancy and lactation

During pregnancy and lactation, the drug should be prescribed only in cases where the expected benefits of therapy for the mother outweigh the potential risk to the fetus or infant.

No adverse effects were reported with the use of zinc pyrithione preparations by pregnant women and women during breastfeeding.

Special instructions

Before using Skin-cap, shake the bottle thoroughly several times.

Keep spray bottle upright while spraying.

For the convenience of treating the scalp, a special nozzle is included.

Composition

Composition per 100 g:

Active ingredient:

Zinc pyrithione activated 0.2 g

excipients:

isopropyl myristate 48.37 g,

polysorbate-80 0.32 g,

trolamine 0.04 g 34.0 g,

water 0.5 g

propellants up to 100 g: isobutane 76.2%, propane 23.29%, butane 0.51%.

Description:

An oily solution from white with a yellowish tinge to light yellow in color with a characteristic odor.

Dosage and administration of

A sufficient amount of the drug from a distance of about 15 cm is sprayed onto the affected skin 2-3 times a day until a clinical effect is achieved. To achieve a lasting effect, the use of the drug is recommended to continue for one week after the disappearance of symptoms. A special nozzle is attached to treat the scalp with a drug. The course of treatment for psoriasis is 1-1.5 months, with atopic dermatitis 3-4 weeks.

Method of administration and doses in pediatrics: method of administration and doses in children do not differ from the method of administration and doses in adults.

If necessary, a second course of treatment can be carried out 1-1.5 months after consulting a doctor.

Side effects

Rarely - allergic reaction.

In the first days of treatment, there may be a short-term burning sensation at the site of application of the drug, which, as a rule, does not require discontinuation of the drug.

Storage conditions

At a temperature of 4 to 30 C.

Out of the reach of children.

Expiration

5 years.

Deystvuyuschee substances

Pyrytyon zinc



over-the-counter pharmacy conditions

over-the-counter

Form of Treatment

spray for outdoor use

Resifarm Parets SL, Spain